Cerity Partners LLC Buys 3,604 Shares of Intuitive Surgical, Inc. $ISRG

Cerity Partners LLC increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.2% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 164,538 shares of the medical equipment provider’s stock after acquiring an additional 3,604 shares during the period. Cerity Partners LLC’s holdings in Intuitive Surgical were worth $89,412,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently made changes to their positions in the stock. Tobam grew its stake in shares of Intuitive Surgical by 666.7% in the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 40 shares in the last quarter. Kilter Group LLC bought a new position in shares of Intuitive Surgical in the 2nd quarter valued at about $27,000. TD Capital Management LLC increased its stake in shares of Intuitive Surgical by 300.0% during the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 45 shares during the last quarter. 1248 Management LLC acquired a new position in shares of Intuitive Surgical during the 1st quarter worth about $30,000. Finally, Princeton Global Asset Management LLC bought a new stake in shares of Intuitive Surgical in the 2nd quarter valued at about $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insiders Place Their Bets

In related news, EVP Myriam Curet sold 7,562 shares of the company’s stock in a transaction on Tuesday, October 28th. The stock was sold at an average price of $548.43, for a total transaction of $4,147,227.66. Following the completion of the sale, the executive vice president directly owned 353 shares in the company, valued at $193,595.79. This represents a 95.54% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Brian Edward Miller sold 3,500 shares of the firm’s stock in a transaction dated Monday, November 10th. The shares were sold at an average price of $575.00, for a total value of $2,012,500.00. Following the completion of the sale, the executive vice president directly owned 5,758 shares in the company, valued at $3,310,850. This trade represents a 37.81% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 108,939 shares of company stock valued at $60,757,995 over the last three months. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Stock Performance

ISRG opened at $575.34 on Monday. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00. The firm has a market cap of $206.25 billion, a P/E ratio of 76.10, a price-to-earnings-growth ratio of 5.29 and a beta of 1.68. The business’s fifty day moving average is $518.60 and its 200-day moving average is $505.04.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. The firm had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The business’s revenue for the quarter was up 22.9% on a year-over-year basis. During the same period in the prior year, the company posted $1.84 earnings per share. On average, research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on ISRG. HSBC lifted their target price on Intuitive Surgical from $595.00 to $644.00 and gave the stock a “buy” rating in a research note on Thursday, October 23rd. Deutsche Bank Aktiengesellschaft reissued a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Wells Fargo & Company increased their price target on shares of Intuitive Surgical from $599.00 to $600.00 and gave the company an “overweight” rating in a report on Wednesday, October 22nd. UBS Group set a $600.00 price objective on Intuitive Surgical and gave the stock a “neutral” rating in a report on Thursday, October 23rd. Finally, Rothschild & Co Redburn increased their target price on Intuitive Surgical from $610.00 to $615.00 and gave the stock a “buy” rating in a research note on Thursday, October 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $607.17.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.